UCB SA (UCBJY)
93.74
+2.57
(+2.82%)
USD |
OTCM |
Nov 22, 16:00
UCB Enterprise Value: 37.88B for Nov. 22, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 22, 2024 | 37.88B |
| November 21, 2024 | 36.90B |
| November 20, 2024 | 36.34B |
| November 19, 2024 | 35.30B |
| November 18, 2024 | 35.56B |
| November 15, 2024 | 35.67B |
| November 14, 2024 | 37.81B |
| November 13, 2024 | 38.85B |
| November 12, 2024 | 38.95B |
| November 11, 2024 | 39.59B |
| November 08, 2024 | 39.94B |
| November 07, 2024 | 39.58B |
| November 06, 2024 | 39.41B |
| November 05, 2024 | 39.72B |
| November 04, 2024 | 39.23B |
| November 01, 2024 | 39.51B |
| October 31, 2024 | 38.73B |
| October 30, 2024 | 39.15B |
| October 29, 2024 | 39.11B |
| October 28, 2024 | 38.78B |
| October 25, 2024 | 38.84B |
| October 24, 2024 | 38.57B |
| October 23, 2024 | 37.84B |
| October 22, 2024 | 37.49B |
| October 21, 2024 | 38.07B |
| Date | Value |
|---|---|
| October 18, 2024 | 38.08B |
| October 17, 2024 | 38.67B |
| October 16, 2024 | 37.81B |
| October 15, 2024 | 38.04B |
| October 14, 2024 | 38.21B |
| October 11, 2024 | 37.75B |
| October 10, 2024 | 37.11B |
| October 09, 2024 | 37.02B |
| October 08, 2024 | 37.08B |
| October 07, 2024 | 36.62B |
| October 04, 2024 | 37.09B |
| October 03, 2024 | 36.85B |
| October 02, 2024 | 36.74B |
| October 01, 2024 | 37.19B |
| September 30, 2024 | 36.54B |
| September 27, 2024 | 36.42B |
| September 26, 2024 | 37.09B |
| September 25, 2024 | 37.86B |
| September 24, 2024 | 37.87B |
| September 23, 2024 | 36.81B |
| September 20, 2024 | 36.83B |
| September 19, 2024 | 36.24B |
| September 18, 2024 | 36.07B |
| September 17, 2024 | 35.75B |
| September 16, 2024 | 37.05B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
11.93B
Minimum
Mar 18 2020
39.94B
Maximum
Nov 08 2024
21.32B
Average
19.65B
Median
Enterprise Value Benchmarks
| Galapagos NV | -1.941B |
| Mithra Pharmaceuticals SA | -- |
| Nyxoah SA | 241.66M |
| Celyad Oncology SA | -- |
| MDxHealth SA | 95.14M |
Enterprise Value Related Metrics
| Earnings Yield | 0.70% |
| Operating Earnings Yield | 1.40% |
| Normalized Earnings Yield | 0.6964 |